Q1 2023 Holdings
Filed 2023-05-15 | 117 holdings | $440.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $7.7K | 6,100 | 0.0% |
| Cyclacel Pharmaceuticals Inc | COM | 23254L603 | $11.0K | 275,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $18.2K | 75 | 0.0% |
| Rocket Pharmaceuticals Inc | *W EXP 09/02/202 | 77313F114 | $60.0K | 367,112 | 0.0% |
| Finch Therapeutics Group Inc | COM | 31773D101 | $93.4K | 237,553 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $95.0K | 136,059 | 0.0% |
| Genfit S A | ADS | 372279109 | $131.5K | 32,786 | 0.0% |
| Spectrum Pharmaceuticals Inc | COM | 84763A108 | $132.7K | 176,980 | 0.0% |
| Bellicum Pharmaceuticals Inc(BLCMEUR) | COM NEW | 079481404 | $147.9K | 448,101 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $148.0K | 65,491 | 0.0% |
| ARK ETF TR(ARKK) | INNOVATION ETF | 00214Q104 | $182.3K | 4,519 | 0.0% |
| Synlogic Inc | COM | 87166L100 | $193.9K | 306,757 | 0.0% |
| Connect Biopharma Hldgs LTD | ADS | 207523101 | $219.5K | 219,501 | 0.0% |
| Erytech Pharma | SPONSORED ADR | 29604W108 | $252.1K | 248,426 | 0.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $267.5K | 962 | 0.1% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $293.4K | 10,000 | 0.1% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $303.7K | 349,133 | 0.1% |
| Chemomab Therapeutics LTD | SPONSORED ADS | 16385C104 | $342.1K | 236,709 | 0.1% |
| Immunogen Inc(IMGNEUR)Call | COM | 45253H101 | $409.3K | 106,600 | 0.1% |
| Anebulo Pharmaceuticals Inc(ANEB) | COM | 034569103 | $462.4K | 156,203 | 0.1% |
| PTC Therapeutics Inc(PTCT)Call | COM | 69366J200 | $474.7K | 9,800 | 0.1% |
| Aslan Pharmaceuticals LTD | SPON ADS NEW | 04522R200 | $475.9K | 164,088 | 0.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $478.6K | 260,087 | 0.1% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $523.5K | 221,830 | 0.1% |
| Immatics N.v(IMTX) | SHS | N44445109 | $526.3K | 179,552 | 0.1% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $584.9K | 188,664 | 0.1% |
| Biohaven LTD(BHVN)Call | COM | G1110E107 | $617.4K | 45,200 | 0.1% |
| Brainstorm Cell Therapeutics(BCLIEUR) | COM NEW | 10501E201 | $626.8K | 189,935 | 0.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $677.2K | 62,766 | 0.2% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $711.4K | 343,685 | 0.2% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $718.5K | 43,156 | 0.2% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $747.1K | 17,805 | 0.2% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $774.1K | 48,170 | 0.2% |
| Krystal Biotech Inc(KRYS)Put | COM | 501147102 | $824.6K | 10,300 | 0.2% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $931.8K | 155,819 | 0.2% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $968.5K | 650,000 | 0.2% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $989.5K | 174,714 | 0.2% |
| Inventiva SA(IVA) | ADS | 46124U107 | $999.2K | 292,599 | 0.2% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $1.0M | 472,625 | 0.2% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $1.0M | 162,527 | 0.2% |
| Point Biopharma Global Inc | COM | 730541109 | $1.0M | 139,565 | 0.2% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $1.0M | 254,945 | 0.2% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $1.1M | 200,000 | 0.2% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $1.1M | 360,569 | 0.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.1M | 140,000 | 0.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.1M | 60,000 | 0.3% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $1.1M | 85,200 | 0.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $1.1M | 8,324 | 0.3% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $1.2M | 300,000 | 0.3% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $1.2M | 33,100 | 0.3% |